• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov6
Huafu Securities Gives Buy Rating to Biocytogen-B Based on Its Future Prospects
07:37
Sep23
Biosyntech Grants IDE034 Project to IDEAYA Biosciences
08:07
Sep18
Biosetum Reports Profit in Q2 2025 Financial Report
02:36
Sep16
BioscieTech Enters into Antibody License Agreement with Tubulis
03:41
Aug28
BIOCYTOGEN-B released FY2025 Q1 earnings on August 28 (BJT), actual revenue HKD 332.52 M, actual EPS HKD 0.0642
15:00
BIOCYTOGEN-B released FY2025 Q2 earnings on August 28 After-Market (BJT), actual revenue HKD 339.83 M, actual EPS HKD 0.0662
11:00

Schedules & Filings

Schedules
Filings
Aug28
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 339.83 M, Net Income 26.27 M, EPS 0.0662

Mar26
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 303.17 M, Net Income 44.8 M, EPS 0.1126

Aug28
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 220.55 M, Net Income -27.22 M, EPS -0.0683

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
00704
0.230
+139.58%
+0.134
00464
1.920
+71.43%
+0.800
00036
0.233
+61.81%
+0.089
03822
1.120
+43.59%
+0.340
03708
0.056
+40.00%
+0.016
01792
0.053
+35.90%
+0.014
00095
0.300
+29.31%
+0.068
08106
0.360
+26.32%
+0.075
02358
0.015
+25.00%
+0.003
01150
0.166
+24.81%
+0.033
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy